ES2067500T3 - 1-indolilalquil-4-(piridinil-sustituidas)piperazinas. - Google Patents

1-indolilalquil-4-(piridinil-sustituidas)piperazinas.

Info

Publication number
ES2067500T3
ES2067500T3 ES89110485T ES89110485T ES2067500T3 ES 2067500 T3 ES2067500 T3 ES 2067500T3 ES 89110485 T ES89110485 T ES 89110485T ES 89110485 T ES89110485 T ES 89110485T ES 2067500 T3 ES2067500 T3 ES 2067500T3
Authority
ES
Spain
Prior art keywords
piridinil
indolylalkyl
piperazines
substituted
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89110485T
Other languages
English (en)
Inventor
David William Smith
Frank D Yocca
Joseph Paul Yevich
Ronald John Mattson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2067500T3 publication Critical patent/ES2067500T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M6/00—Primary cells; Manufacture thereof
    • H01M6/04—Cells with aqueous electrolyte
    • H01M6/06—Dry cells, i.e. cells wherein the electrolyte is rendered non-fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
    • H01M4/00—Electrodes
    • H01M4/02—Electrodes composed of, or comprising, active material
    • H01M4/62—Selection of inactive substances as ingredients for active masses, e.g. binders, fillers
    • H01M4/621—Binders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Electrochemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Manufacturing & Machinery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

UN COMPUESTO DE FORMULA(I) Y SU SAL DE ADICION FARMACEUTICAMENTE ACEPTABLES, DONDE R1 Y R2 SON C1 - 4 ALQUILO INFERIOR O HIDROGENO; R3, R4, R8 Y R9 SE SELECCIONAN DE H, ALQUILO INFERIOR, ALCOXI INFERIOR, CARBAMIDA, HALOGENO, TRIFLUOROMETILO Y TIO - ALQUILO INFERIOR, CON LA CONDICION DE QUE R8 Y R9 NO PUEDEN SER H AL MISMO TIEMPO; A ES UN ANILLO DE 5 A 7 C CICLOALCANILO O CICLOALQUENILO O A ES (II) DONDE N ES DE 1 A 3 Y R5 EL MISMO QUE R1; R6 Y R7 SON SELECCIONADOS DE H, METILO O R6 Y R7 PUEDEN SER TOMADOS JUNTOS COMO PUENTE METILENO, UTILES COMO ANTIDEPRESIVOS
ES89110485T 1988-06-10 1989-06-09 1-indolilalquil-4-(piridinil-sustituidas)piperazinas. Expired - Lifetime ES2067500T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20484588A 1988-06-10 1988-06-10
US07/338,253 US4954502A (en) 1988-06-10 1989-04-14 1-indolyalkyl-4-(substituted-pyridinyl)piperazines

Publications (1)

Publication Number Publication Date
ES2067500T3 true ES2067500T3 (es) 1995-04-01

Family

ID=26899839

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89110485T Expired - Lifetime ES2067500T3 (es) 1988-06-10 1989-06-09 1-indolilalquil-4-(piridinil-sustituidas)piperazinas.

Country Status (17)

Country Link
US (1) US4954502A (es)
EP (1) EP0345808B1 (es)
JP (1) JP2786480B2 (es)
KR (1) KR0128210B1 (es)
AT (1) ATE116982T1 (es)
AU (1) AU624147B2 (es)
CA (1) CA1337421C (es)
CY (1) CY1846A (es)
DE (1) DE68920482T2 (es)
DK (1) DK283589A (es)
ES (1) ES2067500T3 (es)
FI (1) FI95698C (es)
HK (1) HK83295A (es)
IE (1) IE66569B1 (es)
NO (1) NO174296C (es)
PT (1) PT90805B (es)
SG (1) SG32583G (es)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120843A (en) * 1987-04-27 1992-06-09 Upjohn Pharmaceutically active amines
US4975445A (en) * 1989-12-06 1990-12-04 Warner-Lambert Company Substituted cyclohexenes as central nervous system agents
MX9203454A (es) * 1989-12-28 1992-08-01 Upjohn Co Compuestos anti sida diaromaticos substituidos.
US5563142A (en) * 1989-12-28 1996-10-08 The Upjohn Company Diaromatic substituted compounds as anti-HIV-1 agents
US5077293A (en) * 1990-06-29 1991-12-31 Bristol-Myers Squibb Co. 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines
CA2043709C (en) * 1990-06-29 2002-01-22 David W. Smith Antimigraine alkoxypyrimidine derivatives
US5270312A (en) * 1990-11-05 1993-12-14 Warner-Lambert Company Substituted piperazines as central nervous system agents
US5124332A (en) * 1991-01-28 1992-06-23 Warner-Lambert Company Substituted indoles as central nervous system agents
US5177088A (en) * 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5599930A (en) * 1991-07-03 1997-02-04 The Upjohn Company Substituted indoles as anti-AIDS pharmaceuticals
US5206393A (en) * 1991-09-30 1993-04-27 Union Carbide Chemicals & Plastics Technology Corporation Oxa-bicyclic polyfunctional compounds and preparation thereof
US5145973A (en) * 1991-09-30 1992-09-08 Union Carbide Chemicals & Plastics Technology Corporation Oxa-Bicyclic polyfunctional compounds and preparation thereof
US5314896A (en) * 1991-11-20 1994-05-24 Warner-Lambert Company 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
CA2084531A1 (en) * 1991-12-19 1993-06-20 David W. Smith Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines
CA2091204C (en) * 1992-03-11 1997-04-08 Ronald J. Mattson Antiischemic-piperazinyl and piperidinyl-cyclohexanes
AU5715494A (en) * 1992-12-21 1994-07-19 Taisho Pharmaceutical Co., Ltd. N-substituted indole derivative
CA2130078A1 (en) * 1993-09-16 1995-03-17 Jonas A. Gylys Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
US5391570A (en) * 1993-10-14 1995-02-21 Bristol-Myers Squibb Aminomethyl-benzodioxane and benzopyran serotonergic agents
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
US5468767A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antidepressant 3-(aminocycloalkenyl)-indole-5-nitrile derivatives
GB9423682D0 (en) * 1994-11-23 1995-01-11 Merck Sharp & Dohme Therapeutic agents
US5618816A (en) * 1995-03-02 1997-04-08 Bristol-Myers Squibb Company Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines
JPH09124643A (ja) * 1995-08-14 1997-05-13 Bristol Myers Squibb Co 抗うつ作用を有する１−アリールアルキル−４−（アルコキシピリジニル）−又は４−（アルコキシピリミジニル）ピペラジン誘導体
AT403803B (de) * 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
WO1998031679A1 (en) * 1997-01-21 1998-07-23 Yoshitomi Pharmaceutical Industries, Ltd. Thiophene compounds and medicinal use thereof
US6150533A (en) * 1998-04-08 2000-11-21 American Home Products Corp. N-aryloxyethyl-indoly-alkylamines for the treatment of depression
DK1068199T3 (da) * 1998-04-08 2003-03-03 Wyeth Corp N-Aryloxyethyl-indolyl-alkylaminer til behandling af depression
TW520367B (en) * 1998-04-29 2003-02-11 Wyeth Corp Indolyl derivatives as serotonergic agents
FR2786769B1 (fr) * 1998-12-04 2002-10-25 Synthelabo Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
US6313126B1 (en) * 1999-01-07 2001-11-06 American Home Products Corp Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
WO2000040554A1 (en) * 1999-01-07 2000-07-13 American Home Products Corporation Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
EP1146871A4 (en) * 1999-01-28 2002-04-17 Bristol Myers Squibb Co HETEROCYCLIC ANTIDEPRESSANT COMPOUNDS
US7265115B2 (en) 1999-01-29 2007-09-04 Abbott Laboratories Diazabicyclic CNS active agents
EP1228064A1 (en) * 1999-11-08 2002-08-07 Wyeth N-aryl-(homopiperazinyl)-cyclohexyl amines as 5-ht transporters
CN1380883A (zh) 2000-03-31 2002-11-20 萨诺化学药物股份公司 雪花胺的新衍生物和类似物
US6809105B2 (en) 2000-04-27 2004-10-26 Abbott Laboratories Diazabicyclic central nervous system active agents
CA2354606C (en) 2000-08-03 2005-12-06 Pfizer Products Inc. Azabicycloalkane derivatives and therapeutic uses thereof
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
AU2426602A (en) * 2000-11-20 2002-05-27 Biovitrum Ab Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
CA2517291C (en) 2003-03-19 2012-05-08 Exelixis, Inc. Ortho-substituted aryl and heteroaryl tie-2 modulators and methods of use
NZ555491A (en) * 2005-01-03 2010-01-29 Univ Siena Aryl piperazine derivatives for the treatment of neuropsychiatric disorders
JP2009515834A (ja) * 2006-08-29 2009-04-16 テバ ファーマシューティカル インダストリーズ リミティド ５−フェニル−１−トリチル−１ｈ−テトラゾールの合成のための方法
WO2009112139A1 (en) * 2008-03-14 2009-09-17 Merck Patent Gmbh, Azaindole compounds for treatment of central nervous system disorders
CN104163813B (zh) * 2013-05-16 2017-02-01 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
WO2015014256A1 (en) * 2013-07-29 2015-02-05 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use thereof
CN104725363B (zh) * 2013-12-20 2019-03-01 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途
EP3083589B1 (en) * 2013-12-20 2019-12-18 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use thereof
CN106243088B (zh) * 2015-06-03 2019-01-04 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途
CN106795143B (zh) * 2015-08-13 2019-05-24 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
US11285153B2 (en) 2017-09-29 2022-03-29 Sunshine Lake Pharma Co., Ltd. Substituted pyrimidine piperazine compound and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (es) * 1959-09-25 1900-01-01
US3468882A (en) * 1966-10-07 1969-09-23 Sterling Drug Inc Phenylhydrazone derivatives as intermediates for preparing indoles
GB1189064A (en) * 1967-05-01 1970-04-22 Sterling Drug Inc Indole Derivatives
US3472855A (en) * 1967-05-29 1969-10-14 Sterling Drug Inc 1-((benz(g)-indolyl)-lower-alkyl)-4-substituted-piperazines
US4302589A (en) * 1980-05-08 1981-11-24 American Cyanamid Company Cis-mono and disubstituted-2-methyl-3-[(piperazinyl) and (piperidino)ethyl]indolines, intermediates for their preparation and methods of preparation

Also Published As

Publication number Publication date
NO174296C (no) 1994-04-13
HK83295A (en) 1995-06-01
DE68920482D1 (de) 1995-02-23
JP2786480B2 (ja) 1998-08-13
KR0128210B1 (ko) 1998-04-02
CY1846A (en) 1996-03-08
NO892381L (no) 1989-12-11
NO174296B (no) 1994-01-03
DE68920482T2 (de) 1995-06-01
EP0345808A1 (en) 1989-12-13
IE66569B1 (en) 1996-01-24
NO892381D0 (no) 1989-06-09
AU3628289A (en) 1989-12-14
IE891861L (en) 1989-12-10
PT90805A (pt) 1989-12-29
FI892787L (fi) 1989-12-11
PT90805B (pt) 1994-10-31
CA1337421C (en) 1995-10-24
JPH0285277A (ja) 1990-03-26
KR910000708A (ko) 1991-01-30
EP0345808B1 (en) 1995-01-11
SG32583G (en) 1995-09-01
DK283589D0 (da) 1989-06-09
AU624147B2 (en) 1992-06-04
US4954502A (en) 1990-09-04
FI892787A0 (fi) 1989-06-07
ATE116982T1 (de) 1995-01-15
DK283589A (da) 1989-12-11
FI95698B (fi) 1995-11-30
FI95698C (fi) 1996-03-11

Similar Documents

Publication Publication Date Title
NO892381D0 (no) 1-indolylalkyl-4-(substituert-pyridinyl)piperaziner.
ES8703142A1 (es) Proceso para preparar un derivado del bencimidazol.
NL971014I2 (nl) Heterocyclische verbindingen.
ES2062974T3 (es) Compuestos de cefalosporina, procedimientos para su preparacion y agentes antibacterianos.
ES2083464T3 (es) Compuestos heterociclicos.
ES2059327T3 (es) Derivados de tetrahidronaftaleno y de indano, obtencion de los mismos y utilizacion en preparados farmaceuticos.
HUP0003929A2 (hu) Piperazinszármazékok és alkalmazásuk gyulladásgátló hatású gyógyszerkészítmények előállítására, valamint a vegyületeket tartalmazó gyógyszerkészítmények
ES2135416T3 (es) Compuestos de piridopiridazinonas y piridazintionas con actividad inhibidora de la pde iv.
AR247213A1 (es) Preparacion de acido 7-¡(1-carboxi-3-fenilpropil)amino¿-3,4,6,7,8,12b-octahidro-6-oxopirido ¡2,1-a¿ o hexahidro-6-oxo-1h(1,4-tiazino¡3,4-a¿¡2¿-benzazepin-4-carboxilico, agentes hipertensivos.
ES2143487T3 (es) 1,2,4-oxadiazolil-fenoxialquilisoxazoles y su empleo como agentes antivirales.
AR016551A1 (es) Derivados de 2-oxindol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos
ES2060583T3 (es) Nuevos derivados de cefalosporina, procedimiento para su obtencion y preparados farmaceuticos correspondientes.
ES2155827T3 (es) 4-carboxiimidazoles como antagonistas de la angiotensina ii y su uso terapeutico.
SE8505887D0 (sv) Indoler
ES2055867T3 (es) Derivados de dibenzotiazepina utiles como agentes antiespasmodicos.
ES2063831T3 (es) Derivados de 4,5,6,7-tetrahidrobencimidazol y su preparacion.
ES8802149A1 (es) Un procedimiento para la preparacion de derivados de piperazinilo 1,4-disustituidos
MX9303990A (es) Tetrazolil (fenoxi y fenoxialquil) piperidinil piridazinas como agentes antivirales.
ES2078519T3 (es) Acidos hidroxamicos ciclicos y su uso.
ES2081858T3 (es) Compuestos de beta-fenoxinitrilo.
ES2076215T3 (es) Nuevos derivados de imidazol.
AR246972A1 (es) Un procedimiento para producir compuestos de benzodiazepina, y compuestos intermediarios utiles en dicho procedimiento.
ES2054186T3 (es) Composicion antihepatopatica.
MX9303989A (es) Piperidinidil piradizinas fenoxialquilo heterociclicas como agentes antivirales.
ES2046538T3 (es) Derivados de n-feniltetrahidroindazol.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 345808

Country of ref document: ES